Growth Metrics

Oculis Holding AG (OCS) Free Cash Flow Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 60.84%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -15.72%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 66.37%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 3.98%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 137.65%
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 7.12%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.12%
Dec 31, 2025 -72.30%
Sep 30, 2025 -35.06%
Jun 30, 2025 -36.07%
Mar 31, 2025 -34.09%
Dec 31, 2024 24.53%
Sep 30, 2024 9.12%
Jun 30, 2024 -3.26%
Mar 31, 2024 6.92%
Dec 31, 2023 -136.64%
Sep 30, 2023 -89.57%